Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by pennyDoctoron Jul 30, 2015 10:49am
198 Views
Post# 23975736

RE:NPH is a STRONG BUY

RE:NPH is a STRONG BUY Price weakness will be followoed by price strength.  The price here is mostly controlled by the current market weakness that has hit every junior.  Many stockhousers here are not only affected by the weakness of NPH but their many other choices as well.  I still like Intellipharmaceutics TSX I, into generics,  Sirona Biotech SBM.  and PDP Pediapharm.  None of these has the quantity of generics that NPH has and nor do they have the depth of managment that NPH has but two of them have performed well in price over the last month.
The trading of late was more of market rout than any issues with Vanc Pharma.  Watch for block trade in this stock and that will be the beginning of the next big run imho.  Without the block trade the stock will be subject to market dynamics.   This is not a pump and dump also IMHO.   With Commercialization announced this stock in April markets would be hitting new highs,  it is a huge buy signal and if I had more room in my TFSA I would be putting into this stock.

Cheers all!


Bullboard Posts